0001213900-23-059045.txt : 20230724 0001213900-23-059045.hdr.sgml : 20230724 20230724090508 ACCESSION NUMBER: 0001213900-23-059045 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230724 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230724 DATE AS OF CHANGE: 20230724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avalon GloboCare Corp. CENTRAL INDEX KEY: 0001630212 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471685128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38728 FILM NUMBER: 231103873 BUSINESS ADDRESS: STREET 1: 4400 ROUTE 9 STREET 2: SUITE 3100 CITY: FREEHOLD STATE: NJ ZIP: 07728 BUSINESS PHONE: 732-780-4400 MAIL ADDRESS: STREET 1: 4400 ROUTE 9 STREET 2: SUITE 3100 CITY: FREEHOLD STATE: NJ ZIP: 07728 FORMER COMPANY: FORMER CONFORMED NAME: Avalon Globocare Corp. DATE OF NAME CHANGE: 20161018 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL TECHNOLOGIES CORP DATE OF NAME CHANGE: 20150108 8-K 1 ea182223-8k_avalon.htm CURRENT REPORT
0001630212 false 0001630212 2023-07-24 2023-07-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 24, 2023

 

AVALON GLOBOCARE CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38728   47-1685128
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)

 

4400 Route 9 South, Suite 3100

Freehold, New Jersey

  

07728

(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (732) 780-4400

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   ALBT   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 7.01. Regulation FD.

 

On July 24, 2023, Avalon GloboCare Corp. (the “Company”) issued a press release announcing that Laboratory Services MSO, LLC (“Lab Services”), acquired DE Laboratory LLC (“DE Labs”). A copy of the press release is attached hereto as Exhibit 99.1.

 

The information set forth in this Current Report on Form 8-K under Item 7.01, including the information contained in Exhibit 99.1, is being furnished to the Securities and Exchange Commission, and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by a specific reference in such filing.

 

Item 8.01 Other Events.

 

On July 24, 2023, the Company issued a press release announcing that Lab Services acquired DE Labs. The Company owns forty percent (40%) of the issued and outstanding equity interests of Lab Services. DE Labs is a CLIA-certified and COLA-accredited laboratory located in Houston, Texas that offers a wide range of high-quality testing, including drug testing, genetic testing, urinary testing and COVID-19 PCR testing. Lab Servicers is now operating this laboratory as a fully owned subsidiary and has invested growth capital for geographical expansion into the surrounding counties.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) The following exhibit is furnished with this Current Report on Form 8-K:

 

Exhibit No.   Description
99.1   Press Release issued by Avalon GloboCare Corp., dated July 24, 2023.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AVALON GLOBOCARE CORP.
     
Dated:  July 24, 2023 By: /s/ Luisa Ingargiola
  Name:  Luisa Ingargiola
  Title: Chief Financial Officer

 

 

2

 

 

 

 

 EX-99.1 2 ea182223ex99-1_avalon.htm PRESS RELEASE ISSUED BY AVALON GLOBOCARE CORP., DATED JULY 24, 2023

Exhibit 99.1

 

 

 

Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth

 

DE Laboratory in Texas Performs 1,500 Lab Tests Per Month with Focus on Toxicology and Wellness Testing; Expansion Underway

 

FREEHOLD, N.J., July 24, 2023 (GLOBE NEWSWIRE) – Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced Laboratory Services MSO, LLC (“LSM”), has acquired DE Laboratory LLC (“DE Labs”), which expands its penetration within Texas and provides significant potential growth opportunities for the combined company. Avalon owns a 40% interest in LSM.

 

DE Labs is a CLIA-certified and COLA-accredited laboratory located in Houston, Texas that offers a wide range of high-quality testing, including drug testing, genetic testing, urinary testing and COVID-19 PCR testing. LSM is now operating this laboratory as a fully owned subsidiary and has invested growth capital for geographical expansion into the surrounding counties.

 

“This acquisition is just another step towards our goal of expanding LSM through acquisitions and strategic relationships,” commented, David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon. “Our strategy is to take advantage of a unique roll-up opportunity within the highly fragmented market for laboratory testing and services. We continue to target laboratories with exceptional performance, positive revenue track records and niche-market advantages. By leveraging LSM’s experience and infrastructure, we expect to achieve significant synergies with respect to revenue growth and market share.”

 

About Avalon GloboCare Corp.

 

Avalon GloboCare Corp. (NASDAQ: ALBT) is a commercial stage company dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role in the innovation of diagnostic testing, utilizing proprietary technology to deliver precise, genetics-driven results. The Company also provides laboratory services, offering a broad portfolio of diagnostic tests including drug testing, toxicology, and a broad array of test services, from general bloodwork to anatomic pathology, and urine toxicology. For more information about Avalon GloboCare, please visit www.avalon-globocare.com.

 

For the latest updates on Avalon GloboCare’s developments, please follow our twitter at @avalongc_avco

 

Forward-Looking Statements

 

Certain statements contained in this press release may constitute “forward-looking statements.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, including statements regarding LSM. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release.

 

Contact Information:

 

Avalon GloboCare Corp.

4400 Route 9, Suite 3100

Freehold, NJ 07728

PR@Avalon-GloboCare.com

 

Investor Relations:

Crescendo Communications, LLC

Tel: (212) 671-1020 Ext. 304

albt@crescendo-ir.com

 GRAPHIC 3 ex99-1_001.jpg GRAPHIC begin 644 ex99-1_001.jpg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albt-20230724_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 albt-20230724_pre.xml XBRL PRESENTATION FILE EX-101.SCH 6 albt-20230724.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Jul. 24, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 24, 2023
Entity File Number 001-38728
Entity Registrant Name AVALON GLOBOCARE CORP.
Entity Central Index Key 0001630212
Entity Tax Identification Number 47-1685128
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 4400 Route 9 South
Entity Address, Address Line Two Suite 3100
Entity Address, City or Town Freehold
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07728
City Area Code 732
Local Phone Number 780-4400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol ALBT
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 ea182223-8k_avalon_htm.xml IDEA: XBRL DOCUMENT 0001630212 2023-07-24 2023-07-24 iso4217:USD shares iso4217:USD shares 0001630212 false 8-K 2023-07-24 AVALON GLOBOCARE CORP. DE 001-38728 47-1685128 4400 Route 9 South Suite 3100 Freehold NJ 07728 732 780-4400 false false false false Common Stock, par value $0.0001 per share ALBT NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://avalon-globocare.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea182223-8k_avalon.htm albt-20230724.xsd albt-20230724_lab.xml albt-20230724_pre.xml ea182223ex99-1_avalon.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ea182223-8k_avalon.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "ea182223-8k_avalon.htm" ] }, "labelLink": { "local": [ "albt-20230724_lab.xml" ] }, "presentationLink": { "local": [ "albt-20230724_pre.xml" ] }, "schema": { "local": [ "albt-20230724.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ALBT", "nsuri": "http://avalon-globocare.com/20230724", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea182223-8k_avalon.htm", "contextRef": "AsOf2023-07-24", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://avalon-globocare.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ea182223-8k_avalon.htm", "contextRef": "AsOf2023-07-24", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001213900-23-059045-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-059045-xbrl.zip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end